Department of Molecular Pathology, Tokyo Medical University, Shinjuku-ku, Tokyo, 160-8402, Japan.
Department of AI Applied Quantitative Clinical Science, Tokyo Medical University, Shinjuku-ku, Tokyo, 160-8402, Japan.
Mod Pathol. 2021 Feb;34(2):417-425. doi: 10.1038/s41379-020-00671-z. Epub 2020 Sep 18.
Hepatocellular carcinoma (HCC) is a representative primary liver cancer caused by long-term and repetitive liver injury. Surgical resection is generally selected as the radical cure treatment. Because the early recurrence of HCC after resection is associated with low overall survival, the prediction of recurrence after resection is clinically important. However, the pathological characteristics of the early recurrence of HCC have not yet been elucidated. We attempted to predict the early recurrence of HCC after resection based on digital pathologic images of hematoxylin and eosin-stained specimens and machine learning applying a support vector machine (SVM). The 158 HCC patients meeting the Milan criteria who underwent surgical resection were included in this study. The patients were categorized into three groups: Group I, patients with HCC recurrence within 1 year after resection (16 for training and 23 for test); Group II, patients with HCC recurrence between 1 and 2 years after resection (22 and 28); and Group III, patients with no HCC recurrence within 4 years after resection (31 and 38). The SVM-based prediction method separated the three groups with 89.9% (80/89) accuracy. Prediction of Groups I was consistent for all cases, while Group II was predicted to be Group III in one case, and Group III was predicted to be Group II in 8 cases. The use of digital pathology and machine learning could be used for highly accurate prediction of HCC recurrence after surgical resection, especially that for early recurrence. Currently, in most cases after HCC resection, regular blood tests and diagnostic imaging are used for follow-up observation; however, the use of digital pathology coupled with machine learning offers potential as a method for objective postoprative follow-up observation.
肝细胞癌 (HCC) 是一种由长期和反复肝损伤引起的代表性原发性肝癌。手术切除通常被选为根治性治疗方法。由于 HCC 切除后的早期复发与整体生存率降低有关,因此预测切除后的复发具有重要的临床意义。然而,HCC 早期复发的病理特征尚未阐明。我们尝试基于苏木精和伊红染色标本的数字病理图像和应用支持向量机 (SVM) 的机器学习来预测 HCC 切除后的早期复发。本研究纳入了符合米兰标准并接受手术切除的 158 例 HCC 患者。患者被分为三组:I 组,切除后 1 年内 HCC 复发的患者(16 例用于训练,23 例用于测试);II 组,切除后 1-2 年内 HCC 复发的患者(22 例和 28 例);III 组,切除后 4 年内无 HCC 复发的患者(31 例和 38 例)。基于 SVM 的预测方法以 89.9%(80/89)的准确率将三组分开。所有情况下对 I 组的预测都是一致的,而 II 组中有 1 例被预测为 III 组,III 组中有 8 例被预测为 II 组。数字病理学和机器学习的使用可以对手术切除后 HCC 复发进行高度准确的预测,尤其是对早期复发的预测。目前,在大多数 HCC 切除术后,通常使用常规血液检查和诊断性影像学进行随访观察;然而,数字病理学与机器学习的结合为客观的术后随访观察提供了一种潜在方法。